
Pantoprazole Sodium (CAS 138786-67-1) is a potent, third-generation proton pump inhibitor (PPI). It effectively inhibits gastric acid secretion to treat acid-related gastrointestinal disorders in clinical and research settings.
In the field of advanced gastroenterology, the ability to provide long-lasting suppression of gastric acid is a major advantage. Manufacturers specifically select Pantoprazole Sodium because it inhibits the final step of acid production with high precision. For instance, it works more effectively in healing erosive esophagitis and Zollinger-Ellison syndrome than many H2-receptor antagonists. Consequently, it facilitates the production of critical enteric-coated tablets and lyophilized powders for injection. As a result, Zyntex ensures that our pharmaceutical-grade Pantoprazole meets rigorous USP/EP standards. We strictly monitor the moisture content and pH stability to ensure optimal shelf-life in final dosage forms.
Moreover, the industrial-grade Pantoprazole Sodium from Zyntex is a vital component in the development of advanced delayed-release formulations. This application allows for the creation of high-stability clinical products that withstand gastric acidity. Undoubtedly, this pushes the boundaries of what is possible in systemic acid-related therapy. At the same time, global pharmaceutical firms value its role in preventing NSAID-induced gastric ulcers. In short, our product serves as a dependable “precision-reagent.” We support companies focusing on both innovative drug discovery and sustainable pharmaceutical manufacturing.
Recently, scientific interest has surged regarding the use of Pantoprazole in multi-drug protocols for H. pylori eradication. Researchers apply it in complex laboratory models to study drug-drug interaction profiles. Because of this, Zyntex offers specialized bulk formats to ensure safer handling in high-tech laboratory environments. Ultimately, you secure a reliable supply partner by choosing Zyntex. We balance chemical potency with rigorous logistical safety protocols. To conclude, our commitment to chemical excellence ensures that your manufacturing processes—whether in tablet production or injectable formulations—achieve the highest levels of therapeutic efficacy.
This advanced proton pump inhibitor is specifically vital in the following four sectors:
Zyntex supplies this for GERD and ulcer treatments; thus supporting critical care in internal medicine and surgery.
Chemists use it to study gastric ATPase inhibition; consequently it is vital for discovering new GI targets.
It works as a key injectable agent for acute acid management; undoubtedly essential for perioperative patient care.
Zyntex provides high-purity powder for generic manufacturing; specifically helping to lower the cost of essential GI treatments.
| Parameter | Standard Value |
|---|---|
| Product Name | Pantoprazole Sodium Sesquihydrate |
| Assay / Purity | Min. 99.0% (HPLC) |
| Solubility | Freely soluble in water and ethanol |
| CAS Number | 138786-67-1 |
⚠️ Medical Warning: Pantoprazole Sodium is a potent pharmaceutical active ingredient. Therefore, it must only be handled by authorized manufacturers and used strictly according to clinical regulations and professional medical supervision.